Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells.

Conclusion：The combination of anlotinib and DHA showed synergistic antitumor activity, suggesting their potential in treating patients with gastric cancer.
PMID: 32576126 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Biotechnology - June 22, 2020 Category: Biotechnology Authors: Luo Q, Zhang S, Zhang D, Feng R, Li N, Chen W, Chen X, Yang S Tags: Curr Pharm Biotechnol Source Type: research